This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Clarifying the human genome's profile through DNA technology could lead to improved pharmacological therapies. The WGS approach would provide complete genomic variations (including PGx-related markers) for an individual. WES can be used as a molecular diagnostic tool for evaluating genetic illnesses and pharmacogenetic tests by increasing its accuracy and lowering its cost. Precision medicine has a significant place for panel-based testing.